1.975

0.77% 0.015

Caribou Biosciences Inc (CRBU)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CRBU? Forum Prognose

Schlusskurs vom Vortag:

$1.96

Offen:

24-Stunden-Volumen:

740.07K

Relative Volume:

0.64

Marktkapitalisierung:

$176.12M

Einnahmen:

$34.48M

Nettoeinkommen (Verlust:

$-102.07M

KGV:

-1.0852

EPS:

-1.82

Netto-Cashflow:

$-104.90M

1W Leistung:

-5.50%

1M Leistung:

+0.25%

6M Leistung:

-36.08%

1J Leistung:

-62.74%

1-Tages-Spanne:

$1.91

$2.0389

1-Wochen-Bereich:

$1.91

$2.12

52-Wochen-Spanne:

$1.50

$8.33

Caribou Biosciences Inc Stock (CRBU) Company Profile

Firmenname

Caribou Biosciences Inc

Sektor

Healthcare (1195)

Branche

Biotechnology (683)

Telefon

510-982-6030

Adresse

2929 7TH STREET, SUITE 105, BERKELEY

Mitarbeiter

137

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CRBU's Discussions on Twitter

Vergleichen Sie CRBU mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CRBU	1.98	176.12M	34.48M	-102.07M	-104.90M	-1.82
VRTX	449.80	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	747.39	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	593.04	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	245.93	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	107.32	24.89B	3.30B	-501.07M	1.03B	11.54

Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-07-11	Eingeleitet	Truist	Buy
2022-02-18	Eingeleitet	RBC Capital Mkts	Outperform
2021-12-01	Eingeleitet	Oppenheimer	Outperform
2021-11-30	Eingeleitet	H.C. Wainwright	Buy
2021-11-15	Hochstufung	Citigroup	Neutral → Buy
2021-08-17	Eingeleitet	BofA Securities	Buy
2021-08-17	Eingeleitet	Citigroup	Neutral
2021-08-17	Eingeleitet	SVB Leerink	Outperform

Alle ansehen

Caribou Biosciences Inc Aktie (CRBU) Neueste Nachrichten

Nov 20, 2024

Caribou Biosciences to Participate in Upcoming Investor Conferences - The Manila Times

Nov 20, 2024

Caribou Biosciences CEO to Present at Major Healthcare Conferences on CRISPR Advances | CRBU Stock News - StockTitan

Nov 20, 2024

Nov 18, 2024

The Rosen Law Firm, P.A. Announces Proposed Class Action - GlobeNewswire

Nov 18, 2024

The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Caribou Biosciences, Inc. – CRBU - GlobeNewswire Inc.

Nov 18, 2024

Nov 15, 2024

Steven Cohen's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

Nov 15, 2024

Caribou Biosciences (NASDAQ:CRBU) Receives Buy Rating from HC Wainwright - MarketBeat

Nov 15, 2024

PFM Health Sciences, LP Increases Stake in Caribou Biosciences I - GuruFocus.com

Nov 15, 2024

Nov 13, 2024

Caribou Biosciences' SWOT analysis: biotech stock's potential amid clinical trials - Investing.com Australia

Nov 13, 2024

Nov 12, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Third-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For Next Year - Yahoo Finance

Nov 10, 2024

Nov 09, 2024

Caribou Biosciences (NASDAQ:CRBU) Announces Quarterly Earnings Results - MarketBeat

Nov 09, 2024

Caribou Biosciences (NASDAQ:CRBU) vs. Sutro Biopharma (NASDAQ:STRO) Financial Analysis - Defense World

Nov 09, 2024

Nov 08, 2024

Caribou Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 08, 2024

Nov 06, 2024

Caribou Biosciences earnings beat by $0.07, revenue fell short of estimates - Investing.com UK

Nov 06, 2024

Caribou Biosciences reports Q3 EPS (38c), consensus (45c) - TipRanks

Nov 06, 2024

Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update - StockTitan

Nov 06, 2024

CRISPR Technology Market Report 2024, with Profiles of Major Players Agilent Technologies, Beam Therapeutics, Caribou Biosciences, Crispr Therapeutics, Danaher, Genscript, Lonza and MoreResearchAndMarkets.com | FinancialContent Business Page - Financial Content

Nov 06, 2024

Nov 05, 2024

Caribou Biosciences, Inc.'s (NASDAQ:CRBU) Shares Bounce 25% But Its Business Still Trails The Industry - Simply Wall St

Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

Nov 05, 2024

Nov 03, 2024

Critical Analysis: Caribou Biosciences (NASDAQ:CRBU) & Titan Pharmaceuticals (NASDAQ:TTNP) - Defense World

Nov 03, 2024

Oct 31, 2024

Is Caribou Biosciences (CRBU) a Promising Gene Editing Stock? - Insider Monkey

Oct 31, 2024

Oct 30, 2024

10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds - Insider Monkey

Oct 30, 2024

Oct 22, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Bought by Exchange Traded Concepts LLC - Defense World

Oct 22, 2024

Oct 17, 2024

STATE STREET CORP's Strategic Acquisition in Caribou Biosciences Inc - GuruFocus.com

Oct 17, 2024

Following a 49% decline over last year, recent gains may please Caribou Biosciences, Inc. (NASDAQ:CRBU) institutional owners - Simply Wall St

Oct 17, 2024

Oct 16, 2024

Its Stock Has Paid Off Big Time For Caribou Biosciences Inc - SETE News

Oct 16, 2024

Oct 15, 2024

How to interpret Caribou Biosciences Inc (CRBU)’s stock chart patterns - US Post News

Oct 15, 2024

Oct 14, 2024

Daily Market Movement: Caribou Biosciences Inc (CRBU) Sees a 5.56 Increase, Closing at 1.90 - The Dwinnex

Oct 14, 2024

Oct 10, 2024

Dimensional Fund Advisors LP Has $4.30 Million Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU) - MarketBeat

Oct 10, 2024

Oct 09, 2024

A better buy-in window may exist right now for Caribou Biosciences Inc (CRBU) - SETE News

Oct 09, 2024

Oct 08, 2024

Caribou Biosciences, Inc. (NASDAQ:CRBU) Shares Purchased by Green Alpha Advisors LLC - Defense World

Oct 08, 2024